Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like New Jersey Startup Launches With Clinical Assets From Big Name Biotechs August 21, 2017 SpineGuard Raises ???2 Million Of Fresh Equity Finance April 6, 2017 Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million February 28, 2018
